Structure Therapeutics Inc. SEC filings GPCR

Structure Therapeutics Inc. has 271 filings in SEC EDGAR's recent list, going back to Oct 21, 2021. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Structure Therapeutics Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2026 Sep 8, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 17, 2026
8-K Current report
Material agreement, Results of operations, Other events
May 7, 2026 May 7, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 15, 2026 Apr 15, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 16, 2026 Mar 16, 2026
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Material agreement
Jan 5, 2026 Dec 30, 2025
8-K Current report
Other events
Dec 10, 2025 Dec 9, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2025 Dec 8, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Shareholder vote results
Jun 25, 2025 Jun 23, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Regulation FD disclosure
Dec 17, 2024 Dec 17, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Sep 17, 2024 Sep 12, 2024
8-K Current report
Officer or director change
Aug 27, 2024 Aug 24, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results, Other events
Jun 27, 2024 Jun 25, 2024
8-K Current report
Other events
Jun 3, 2024 Jun 3, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2024 Jun 3, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
8-K Current report
Results of operations
Mar 8, 2024 Mar 8, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 18, 2023 Dec 18, 2023
8-K Current report
Material agreement, Results of operations
Nov 14, 2023 Nov 7, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Sep 29, 2023 Sep 29, 2023
8-K Current report
Regulation FD disclosure
Sep 29, 2023 Sep 29, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Officer or director change
Aug 4, 2023 Aug 3, 2023
8-K Current report
Material agreement
Jul 6, 2023 Jun 29, 2023
8-K Current report
Auditor change
Jun 5, 2023 May 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Results of operations
Mar 30, 2023 Mar 30, 2023
8-K Current report
Bylaw or fiscal year change
Feb 7, 2023 Feb 7, 2023

Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GPCR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1888886
Former names
ShouTi Inc. (until May 13, 2022)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.